Syndecan-1: A new prognostic marker in laryngeal cancer

Acta Oto-Laryngologica

Volumn 117, Issue 2, 1997, Pages 312-315

  Pulkkinen, Jaakko O ^a   Penttinen, Marjatta ^b   Jalkanen, Markku ^b   Klemi, Pekka ^a   Grénman, Reidar ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

Author keywords

head and neck cancer; heparan sulphate; Ki 67; Mab 104 9; prognostic factors

Indexed keywords

SYNDECAN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; CONFERENCE PAPER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030980717     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016489709117794     Document Type: Conference Paper

References (13)

1. Frenette PS, Wagner DD. Adhesion molecules: Part I. N Engl J Med 1996; 334: 1526-9.
2. Bernfield M, Kokenyesi R, Kato M, et al. Biology of the syndecans. Annu Rev Cell Biol 1992; 8: 365-93.
3. Elenius K, Jalkanen M. Function of the syndecans - a family of cell surface proteoglycans. J Cell Sci 1994; 107: 2975-82.
4. Inki P, Jalkanen M. The role of syndecan-1 in malignancies. Ann Med 1996; 28: 63-7.
5. Inki P, Joensuu H, Grénman R, Klemi P, Jalkanen M. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer 1994; 70: 319-23.
6. Roland NJ, Caslin AW, Bowie GL, Jones AS. Has the cellular proliferation marker Ki67 any clinical relevance in squamous cell carcinoma of the head and neck? Clin Otolaryngol 1994; 19: 13-8.
7. Shanmugaratnam K, ed. WHO: Histological typing of tumours of the upper respiratory tract and ear 2nd ed. Berlin: Springer-Verlag, 1991.
8. Klemi PJ, Pylkkänen L, Kiilholma P, Joensuu H. p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma. Cancer 1995; 76: 1201-8.
9. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1-39.
10. Cox DR. Regression models and life tables with discussion. J R Stat 1972; 34: 187-220.
11. Carter RL. Pathology of squamous carcinomas of the head and neck. Curr Opin Oncol 1991; 3: 507-11.
12. Wiernik G, Millard PR, Haybittle JL. The predictive value of histological classification into degrees of differentiation of squamous cell carcinoma of the larynx and hypopharynx compared with the survival of patients. Histopathology 1991; 19: 411-7.
13. Truelson JM, Fisher SG, Beals TE, McClatchey KD, Wolf GT, The Department of Veterans Affairs Co-operative Laryngeal Cancer Study Group. DNA content and histological growth pattern correlate with prognosis in patients with advanced squamous cell carcinoma of the larynx. Cancer 1992; 70: 56-62.